Total Payments
$5,103
2024 Payments
$1,026
Companies
19
Transactions
274
Medicare Patients
5,989
Medicare Billing
$301,721
Payment Breakdown by Category
Food & Beverage$5,023 (98.4%)
Education$79.99 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,023 | 273 | 98.4% |
| Education | $79.99 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $876.99 | 52 | $0 (2024) |
| Janssen Biotech, Inc. | $794.27 | 49 | $0 (2024) |
| UCB, Inc. | $708.64 | 36 | $0 (2024) |
| GENZYME CORPORATION | $573.33 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $401.18 | 24 | $0 (2024) |
| Lilly USA, LLC | $379.73 | 20 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $275.21 | 15 | $0 (2024) |
| Amgen Inc. | $230.18 | 9 | $0 (2023) |
| Incyte Corporation | $209.26 | 8 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $206.98 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,026 | 48 | GENZYME CORPORATION ($276.77) |
| 2023 | $1,597 | 90 | Janssen Biotech, Inc. ($412.06) |
| 2022 | $1,186 | 67 | ABBVIE INC. ($212.83) |
| 2021 | $1,293 | 69 | AbbVie Inc. ($528.15) |
All Payment Transactions
274 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Immunology | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Immunology | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Immunology | ||||||
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.92 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: DERMATOLOGY | ||||||
| 10/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: Immunology | ||||||
| 10/01/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Dermatology | ||||||
| 09/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: DERMATOLOGY | ||||||
| 09/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Immunology | ||||||
| 09/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: DERMATOLOGY | ||||||
| 08/26/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Immunology | ||||||
| 08/20/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $21.08 | General |
| 08/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Immunology | ||||||
| 08/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Immunology | ||||||
| 07/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Immunology | ||||||
| 07/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Immunology | ||||||
| 07/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.46 | General |
| Category: Immunology | ||||||
| 07/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: Immunology | ||||||
| 06/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Immunology | ||||||
| 06/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: DERMATOLOGY | ||||||
| 06/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,104 | 1,853 | $146,055 | $57,835 |
| 2022 | 12 | 1,171 | 1,946 | $177,130 | $63,900 |
| 2021 | 12 | 1,380 | 2,331 | $217,125 | $69,052 |
| 2020 | 13 | 2,334 | 3,995 | $374,955 | $110,934 |
Total Patients
5,989
Total Services
10,125
Medicare Billing
$301,721
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 294 | 372 | $36,470 | $20,237 | 55.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 144 | 155 | $31,000 | $9,565 | 30.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 186 | 230 | $36,800 | $8,424 | 22.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 137 | 159 | $10,335 | $5,322 | 51.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 60 | 60 | $7,500 | $3,740 | 49.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 94 | 94 | $7,990 | $3,659 | 45.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 138 | 726 | $7,260 | $3,134 | 43.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 24 | 28 | $3,880 | $2,203 | 56.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 12 | 12 | $3,120 | $958.98 | 30.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 15 | 17 | $1,700 | $592.09 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 283 | 336 | $31,920 | $18,896 | 59.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 190 | 235 | $37,600 | $8,980 | 23.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 130 | 138 | $27,600 | $8,890 | 32.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 141 | 177 | $11,505 | $6,378 | 55.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 127 | 127 | $10,795 | $5,112 | 47.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 74 | 74 | $9,250 | $4,813 | 52.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 38 | 47 | $6,110 | $3,472 | 56.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 138 | 753 | $31,450 | $3,447 | 11.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 12 | 17 | $4,420 | $1,878 | 42.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 11 | 11 | $2,860 | $726.04 | 25.4% |
| 69100 | Biopsy of ear | Office | 2022 | 13 | 13 | $1,820 | $689.72 | 37.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 14 | 18 | $1,800 | $618.68 | 34.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 368 | 424 | $40,170 | $21,285 | 53.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 153 | 164 | $32,800 | $9,758 | 29.8% |
| 17000 | Destruction of skin growth | Office | 2021 | 233 | 270 | $43,200 | $9,322 | 21.6% |
About Mike Bevers
Mike Bevers is a Physician Assistant healthcare provider based in Rehoboth Beach, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508899485.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mike Bevers has received a total of $5,103 in payments from pharmaceutical and medical device companies, with $1,026 received in 2024. These payments were reported across 274 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($5,023).
As a Medicare-enrolled provider, Bevers has provided services to 5,989 Medicare beneficiaries, totaling 10,125 services with total Medicare billing of $301,721. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Rehoboth Beach, DE
- Active Since 07/07/2006
- Last Updated 10/10/2016
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1508899485
Products in Payments
- DUPIXENT (Biological) $808.52
- TREMFYA (Drug) $685.43
- Cimzia (Drug) $518.74
- SKYRIZI (Biological) $458.61
- TALTZ (Drug) $379.73
- HUMIRA (Biological) $268.48
- Otezla (Drug) $230.18
- OPZELURA (Drug) $209.26
- Sotyktu (Drug) $206.98
- Bimzelx (Biological) $189.90
- COSENTYX (Biological) $165.43
- COSENTYX (Drug) $160.08
- RINVOQ (Biological) $149.90
- ADBRY (Biological) $131.32
- REMICADE (Biological) $108.84
- VTAMA (Drug) $60.33
- EUCRISA (Drug) $59.32
- LIBTAYO (Biological) $40.02
- IDACIO (Biological) $29.38
- ILUMYA (Biological) $26.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Rehoboth Beach
Patrick Duffy, Pa, PA
Physician Assistant — Payments: $3,759
Physician Assistant $3,759
Alexander Chase, Pa-C, PA-C
Physician Assistant — Payments: $644.71
Physician Assistant $644.71
Robert Barwick, Pa, PA
Physician Assistant — Payments: $569.97
Physician Assistant $569.97
Noor Al-Rashid
Physician Assistant — Payments: $150.04
Physician Assistant $150.04
Ms. Tricia Ecker, Pa-C, PA-C
Physician Assistant — Payments: $18.04
Physician Assistant $18.04
Andrew Fitzkee, P.a, P.A
Physician Assistant
Physician Assistant